AzurRx BioPharma adds two additional clinical trial sites in Poland
Poland
Ryvu Therapeutics obtains Poland nod for Phase I/II cancer study
The new study will evaluate RVU120’s safety, tolerability, PK, PD and preliminary anti-tumour activity.
Cyxone to begin Phase II trial of oral Covid-19 drug
WPD and CNS partner for paediatric brain cancer trial
Moleculin augments two anti-cancer clinical trials in Poland
M&As this week: Orion Biotechnology Canada, SOPHiA GENETICS, GI Partners
Deals this week: Ultragenyx Pharmaceutical, Insmed, Harbour BioMed
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox